| Year |
Citation |
Score |
| 2019 |
Shields M, Scully S, Sulman H, Borba C, Trinh NH, Singer S. Consumers' Suggestions for Improving the Mental Healthcare System: Options, Autonomy, and Respect. Community Mental Health Journal. 55: 916-923. PMID 31175515 DOI: 10.1007/S10597-019-00423-7 |
0.322 |
|
| 2013 |
Fekadu A, Mesfin M, Medhin G, Alem A, Teferra S, Gebre-Eyesus T, Seboxa T, Assefa A, Hussein J, Lemma MT, Borba C, Henderson DC, Hanlon C, Shibre T. Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial. Trials. 14: 406. PMID 24279305 DOI: 10.1186/1745-6215-14-406 |
0.331 |
|
| 2013 |
Chemali ZN, Borba CP, Henderson TE, Tesfaye M. Making strides in women's mental health care delivery in rural Ethiopia: demographics of a female outpatient psychiatric cohort at Jimma University Specialized Hospital (2006-2008). International Journal of Women's Health. 5: 413-9. PMID 23901297 DOI: 10.2147/Ijwh.S43617 |
0.377 |
|
| 2012 |
Borba CP, DePadilla L, McCarty FA, von Esenwein SA, Druss BG, Sterk CE. A qualitative study examining the perceived barriers and facilitators to medical healthcare services among women with a serious mental illness. Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health. 22: e217-24. PMID 22172651 DOI: 10.1016/J.Whi.2011.10.001 |
0.513 |
|
| 2011 |
Borba CP, Depadilla L, Druss BG, McCarty FA, von Esenwein SA, Sterk CE. A day in the life of women with a serious mental illness: a qualitative investigation. Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health. 21: 286-92. PMID 21330152 DOI: 10.1016/J.Whi.2010.11.003 |
0.513 |
|
| 2009 |
Henderson DC, Fan X, Copeland PM, Sharma B, Borba CP, Forstbauer SI, Miley K, Boxill R, Freudenreich O, Cather C, Evins AE, Goff DC. Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia. Human Psychopharmacology. 24: 225-32. PMID 19283774 DOI: 10.1002/Hup.1012 |
0.37 |
|
| 2009 |
Henderson DC, Fan X, Sharma B, Copeland PM, Borba CP, Boxill R, Freudenreich O, Cather C, Eden Evins A, Goff DC. A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with Schizophrenia Acta Psychiatrica Scandinavica. 119: 457-465. PMID 19183127 DOI: 10.1111/J.1600-0447.2008.01325.X |
0.319 |
|
| 2008 |
Fan X, Henderson DC, Nguyen DD, Cather C, Freudenreich O, Evins AE, Borba CP, Goff DC. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia. Psychiatry Research. 159: 140-6. PMID 18423611 DOI: 10.1016/J.Psychres.2007.10.012 |
0.309 |
|
| 2008 |
Henderson DC, Kapetanovic A, Culhane MA, Lavelle J, Miley K, Gray D, Borba CP, Mollica RF. Building primary care practitioners’ attitudes and confidence in mental health skills in post-conflict Bosnia and Herzegovina International Journal of Culture and Mental Health. 1: 117-133. DOI: 10.1080/17542860802456653 |
0.313 |
|
| 2007 |
Henderson DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, Freudenreich O, Goff DC. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. The Journal of Clinical Psychiatry. 68: 533-41. PMID 17474808 DOI: 10.4088/Jcp.V68N0407 |
0.314 |
|
| 2007 |
Henderson DC, Fan X, Copeland PM, Borba CP, Daley TB, Nguyen DD, Zhang H, Hayden D, Freudenreich O, Cather C, Evins AE, Goff DC. A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain Acta Psychiatrica Scandinavica. 115: 101-105. PMID 17244173 DOI: 10.1111/J.1600-0447.2006.00855.X |
0.311 |
|
| 2006 |
Fan X, Anderson EJ, Copeland PM, Borba CP, Nguyen DD, Freudenreich O, Goff DC, Henderson DC. Higher fasting serum insulin is associated with increased resting energy expenditure in nondiabetic schizophrenia patients. Biological Psychiatry. 60: 1372-7. PMID 16920075 DOI: 10.1016/J.Biopsych.2006.05.006 |
0.304 |
|
| 2006 |
Henderson DC, Copeland PM, Borba CP, Daley TB, Nguyen DD, Cagliero E, Evins AE, Zhang H, Hayden DL, Freudenreich O, Cather C, Schoenfeld DA, Goff DC. Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis. The Journal of Clinical Psychiatry. 67: 789-97. PMID 16841629 DOI: 10.4088/Jcp.V67N0513 |
0.352 |
|
| 2006 |
Henderson DC, Borba CP, Daley TB, Boxill R, Nguyen DD, Culhane MA, Louie P, Cather C, Eden Evins A, Freudenreich O, Taber SM, Goff DC. Dietary intake profile of patients with schizophrenia. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 18: 99-105. PMID 16754415 DOI: 10.1080/10401230600614538 |
0.354 |
|
| 2006 |
Henderson DC, Kunkel L, Nguyen DD, Borba CP, Daley TB, Louie PM, Freudenreich O, Cather C, Evins AE, Goff DC. An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia. Acta Psychiatrica Scandinavica. 113: 142-7. PMID 16423166 DOI: 10.1111/J.1600-0447.2005.00612.X |
0.332 |
|
| 2005 |
Henderson DC, Copeland PM, Daley TB, Borba CP, Cather C, Nguyen DD, Louie PM, Evins AE, Freudenreich O, Hayden D, Goff DC. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. The American Journal of Psychiatry. 162: 954-62. PMID 15863798 DOI: 10.1176/Appi.Ajp.162.5.954 |
0.302 |
|
| 2005 |
Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Archives of General Psychiatry. 62: 19-28. PMID 15630069 DOI: 10.1001/Archpsyc.62.1.19 |
0.339 |
|
| Show low-probability matches. |